PMID

Data

Article Title

Organization

Fluorescent ligands for adenosine receptors.

National Institute of Diabetes and Digestive and Kidney Diseases

QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists.

University of Pisa

5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.

Universit£

Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.

Universit£

1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.

Universit£

Synthesis, molecular modeling studies, and pharmacological activity of selective A(1) receptor antagonists.

Universit£

3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: a new class of selective A1 adenosine receptor antagonists.

Universit£

A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.

Universit£

2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.

Universit£

Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.

Kyowa Hakko Kogyo

Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Niddk

Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists.

National Institute of Diabetes

1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.

Center For Bio-Pharmaceutical Sciences

Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.

Niddk

125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.

University of Virginia School of Medicine

Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.

TBA

Adenosine receptors: targets for future drugs.

TBA

The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists.

Universita` Degli Studi Di Firenze

Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.

Dipartimento Di Scienze Farmaceutiche

 

Synthesis of 5-(3-Hydroxypropyl)-7-methoxy-2-(3‘-methoxy-4‘-hydroxyphenyl)-3- benzo[b]furancarbaldehyde, a Novel Adenosine A₁ Receptor Ligand from the Root of Salvia miltiorrhiza

TBA

Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

Universita Di Firenze

Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.

Universita' Di Firenze

Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptors.

Università

4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

Università

1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.

Università

Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.

Università

1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors.

Dipartimento Di Scienze Farmaceutiche

Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives.

Università

Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): a potent and selective A(1)-adenosine receptor antagonist for in vivo imaging.

Forschungszentrum JüLich

Design, synthesis and biological evaluation of novel N-alkyl- and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs) as novel A(1) adenosine receptor antagonists.

Università

Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands.

Facoltà

Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.

Universita' Di Firenze

1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists.

Universita' Di Firenze

Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.

Università

A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET).

Forschungszentrum JüLich

8-Azaxanthine derivatives as antagonists of adenosine receptors.

Università

Neurotransmitter receptor binding and drug discovery.

TBA

Imidazo[1,2-?]pyridines possess adenosine A

North-West University

Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1.

University of North Carolina At Chapel Hill